Merck KGaA

Merck of Germany
Biotech

Merck KGaA buys Silence in $1.3B deal for blood cancer drug

Germany’s Merck KGaA picked up Silence to the tune of $1.3 billion following the biotech’s mid-stage success for its challenger to Takeda’s Mimrylo.
James Waldron Oct 19, 2026 8:57am
close-up image of an eye

Merck KGaA spinout iOnctura touts PI3K inhibitor in eye cancer

Oct 14, 2026 1:42pm
A series of dice with a bag on them illustrating cost cuts

Merck KGaA makes further cuts to US research team

Aug 17, 2026 1:23pm
Company logo on the outside of a building at the EMD Serono Research Development Institute in Billerica Massachusetts

Merck KGaA in-office requirement could lead to 70 US layoffs

Jul 13, 2026 2:32pm
heart money

Merck KGaA pledges $50M to new biotech with eye to acquisition

Jun 23, 2026 10:16am
Illustration for Fierces Chutes Ladders feature showing a blue city skyline with executives making career moves o

Perrigo CEO ousted over ‘personal conduct’—Chutes & Ladders

Jun 12, 2026 8:30am